For years, private-equity money powered a vigorous M&A market. But the ongoing credit crunch has caused many private-equity buyers to flee their up-market deals. This mass flight has, in turn, put merger agreement remedy provisions in the spotlight.2 In the third article in our series3 discussing lessons from the meltdown, we address the implications of the recent judicial focus on remedy provisions.